Vimarsana
Biggest News Aggregation in the World

Page 37 - Spring House News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spring House. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spring House Today - Breaking & Trending Today

How sweet it is - Observer-Reporter - Vimarsana News

How sweet it is - Observer-Reporter

The Washington City Mission’s 30th anniversary Sweet Sunday Dessert Festival will be held from noon to 5 p.m. Sunday at the Hilton Garden Inn at Southpointe. The City Mission’s largest fundraiser of the year will feature 27 vendors including Sarris Candies, Bethel Bakery and The Spring House, as well as raffle baskets, auction items, a […]

How sweet it is - Herald-Standard - Vimarsana News

How sweet it is - Herald-Standard

The Washington City Mission’s 30th anniversary Sweet Sunday Dessert Festival will be held from noon to 5 p.m. Sunday at the Hilton Garden Inn at Southpointe. The City Mission’s largest fundraiser of the year will feature 27 vendors including Sarris Candies, Bethel Bakery and The Spring House, as well as raffle baskets, auction items, a […]

SC hires and promotions - Vimarsana News

SC hires and promotions

Engineering

Club News | Local News | bedfordgazette.com - Vimarsana News

Club News | Local News | bedfordgazette.com

Woodland Owners of the Southern Alleghenies (WOSA) will host a conference for landowners, foresters, loggers, and anyone who enjoys being in the woods. The conference will take place March 9

Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine - Vimarsana News

Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine

/PRNewswire/ -- Johnson & Johnson today announced publication in the New England Journal of Medicine (NEJM) of the Phase 2b FRONTIER 1 trial results for...